Skip to main content
Journal cover image

In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.

Publication ,  Journal Article
Yergey, JA; Trimble, LA; Silva, J; Chauret, N; Li, C; Therien, M; Grimm, E; Nicoll-Griffith, DA
Published in: Drug metabolism and disposition: the biological fate of chemicals
May 2001

The metabolic profile of DFU [5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone], a potent and selective COX-2 inhibitor, was characterized using in vitro microsomal and hepatocyte incubations. A single product, corresponding to p-hydroxylation, p-OH-DFU [(5,5-dimethyl-3-(3-fluoro-4-hydroxyphenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone)], was produced in rat microsomal incubations of DFU. In contrast, three metabolites were produced in incubations using suspensions of freshly isolated rat hepatocytes. Microsomal production of the p-O-glucuronide metabolite of DFU from synthetic p-OH-DFU was shown to have chromatographic and mass spectrometric properties identical to the earliest eluting hepatocyte metabolite (M1). The molecular weights of the other two hepatocyte metabolites were readily obtained using capillary high-performance liquid chromatography continuous-flow liquid secondary ion mass spectrometry (HPLC/CF-LSIMS); however, the elemental composition of these metabolites was not. Unlike typical metabolic products, which produce readily identified increments in molecular weight, metabolites M2 and M3 produced molecular ions in positive- and negative-ion CF-LSIMS that were consistent with oxidation of DFU (+16 Da), followed by addition of glutathione (+306 Da) and subsequent loss of 20 and 18 Da, respectively. Capillary HPLC/high-resolution CF-LSIMS was used to generate accurate mass data for M2 and M3 that provided evidence that the losses of 20 and 18 Da, respectively, corresponded to a rearomatization through loss of HF or H(2)O. Isolation and NMR characterization provided the definitive structural proof for these metabolites. Overall, the metabolism of DFU in rat hepatocytes is proposed to proceed through an epoxide intermediate, which then either rearranges to the p-OH-DFU and is conjugated with glucuronic acid, or is trapped with glutathione, followed by rearomatization with loss of HF (M2) or H(2)O (M3).

Duke Scholars

Published In

Drug metabolism and disposition: the biological fate of chemicals

EISSN

1521-009X

ISSN

0090-9556

Publication Date

May 2001

Volume

29

Issue

5

Start / End Page

638 / 644

Related Subject Headings

  • Rats, Sprague-Dawley
  • Rats
  • Prostaglandin-Endoperoxide Synthases
  • Pharmacology & Pharmacy
  • Microsomes
  • Mass Spectrometry
  • Male
  • Magnetic Resonance Spectroscopy
  • Isoenzymes
  • Glutathione
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yergey, J. A., Trimble, L. A., Silva, J., Chauret, N., Li, C., Therien, M., … Nicoll-Griffith, D. A. (2001). In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 29(5), 638–644.
Yergey, J. A., L. A. Trimble, J. Silva, N. Chauret, C. Li, M. Therien, E. Grimm, and D. A. Nicoll-Griffith. “In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.Drug Metabolism and Disposition: The Biological Fate of Chemicals 29, no. 5 (May 2001): 638–44.
Yergey JA, Trimble LA, Silva J, Chauret N, Li C, Therien M, et al. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization. Drug metabolism and disposition: the biological fate of chemicals. 2001 May;29(5):638–44.
Yergey, J. A., et al. “In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 29, no. 5, May 2001, pp. 638–44.
Yergey JA, Trimble LA, Silva J, Chauret N, Li C, Therien M, Grimm E, Nicoll-Griffith DA. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization. Drug metabolism and disposition: the biological fate of chemicals. 2001 May;29(5):638–644.
Journal cover image

Published In

Drug metabolism and disposition: the biological fate of chemicals

EISSN

1521-009X

ISSN

0090-9556

Publication Date

May 2001

Volume

29

Issue

5

Start / End Page

638 / 644

Related Subject Headings

  • Rats, Sprague-Dawley
  • Rats
  • Prostaglandin-Endoperoxide Synthases
  • Pharmacology & Pharmacy
  • Microsomes
  • Mass Spectrometry
  • Male
  • Magnetic Resonance Spectroscopy
  • Isoenzymes
  • Glutathione